Home
>
National Drug Code (NDC)
>
Atelvia
Atelvia - 0430-0979-03 - (risedronate sodium)
Drug Information of Atelvia
| Product NDC: | 0430-0979 |
| Proprietary Name: | Atelvia |
| Non Proprietary Name: | risedronate sodium |
| Active Ingredient(s): | 30.1; 4.9 mg/1; mg/1 & nbsp; risedronate sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Atelvia
| Product NDC: | 0430-0979 |
| Labeler Name: | Warner Chilcott (US), LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022560 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101201 |
Package Information of Atelvia
| Package NDC: | 0430-0979-03 |
| Package Description: | 36 DOSE PACK in 1 CASE (0430-0979-03) > 4 TABLET, DELAYED RELEASE in 1 DOSE PACK |
NDC Information of Atelvia
| NDC Code | 0430-0979-03 |
| Proprietary Name | Atelvia |
| Package Description | 36 DOSE PACK in 1 CASE (0430-0979-03) > 4 TABLET, DELAYED RELEASE in 1 DOSE PACK |
| Product NDC | 0430-0979 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | risedronate sodium |
| Dosage Form Name | TABLET, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20101201 |
| Marketing Category Name | NDA |
| Labeler Name | Warner Chilcott (US), LLC |
| Substance Name | RISEDRONATE SODIUM HEMI-PENTAHYDRATE; RISEDRONATE SODIUM MONOHYDRATE |
| Strength Number | 30.1; 4.9 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient],Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |
